Activity of Antitumor Drugs Against African Trypanosomes
AUTOR(ES)
Kinnamon, Kenneth E.
RESUMO
Of 49 compounds known to have antitumor properties, 6 were found to have significant activity against Trypanosoma rhodesiense infections in mice. Activity against the African trypanosomes has not been reported previously for any of these six compounds. In order of decreasing activity these compounds were: (i) imidazole-4-carboxamide, 5-(3,3-dimethyl-1,1-triazene), (ii) inosine diglycolaldehyde, (iii) cis-diamminedichloro-platinum, (iv) streptozotocin, (v) coralyne sulfate, and (vi) 5-fluoro-2′-deoxyuridine. The percentage of “hits” (12.2%) from these known antitumor agents was approximately twice as great as when other means are employed for the selection of compounds for this test system.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=352625Documentos Relacionados
- Trypanothione is the primary target for arsenical drugs against African trypanosomes.
- Biologically active products from African Trypanosomes.
- Toxicity of myristic acid analogs toward African trypanosomes.
- Evidence for diploidy in metacyclic forms of African trypanosomes.
- Loop-Mediated Isothermal Amplification for Detection of African Trypanosomes